血友病A携带者对去氨加压素反应降低且持续时间缩短,导致出血
本研究比较血友病A携带者与正常对照对去氨加压素(DDAVP)的反应,携带者年龄中位数34岁高于对照21岁(P=.003),ISTH-BAT出血评分中位数8分高于对照0分(P=.001);携带者FVIII反应显著降低(P≤.0001),且出血评分异常者FVIII反应亦显著低于评分正常者(P=.036)。
要点
- 血友病A携带者对DDAVP的FVIII反应显著低于正常对照(P≤.0001)。
- 仅纳入基线FVIII正常的携带者时,FVIII反应仍显著降低(P≤.0001)。
- 出血评分异常者DDAVP后FVIII反应显著低于评分正常者(P=.036)。
核心结论
- 血友病A携带者对DDAVP的FVIII反应更低且持续时间更短,提示其对止血应激的反应能力受损,从而导致出血。
研究设计与样本
- 研究比较血友病A携带者与正常对照对DDAVP的反应;DDAVP按0.3 μg/kg经静脉或皮下给药,基线及给药后1、2、4小时采血检测。
主要发现
- 携带者年龄中位数34岁 vs 对照21岁(P=.003),ISTH-BAT出血评分中位数8分 vs 对照0分(P=.001)。
- 携带者DDAVP后FVIII反应显著低于对照(P≤.0001)。
- 仅纳入基线FVIII正常的携带者(n=10)时,FVIII反应仍显著低于对照(P≤.0001)。
- 出血评分异常者DDAVP后FVIII反应显著低于出血评分正常者(P=.036)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The cause of hemophilia A carrier bleeding is not well established. Desmopressin (DDAVP), used clinically to treat or prevent bleeding, can also be used as a medical stress surrogate. This study's objective was to compare the response to DDAVP in hemophilia A carriers with that in normal control patients. Bleeding was assessed by the International Society on Thrombosis and Hemostasis Bleeding Assessment Tool (ISTH-BAT). DDAVP (0.3 μg/kg) was administered either IV or subcutaneously (SC), and blood was drawn at baseline and 1, 2, and 4 hours postadministration. Blood was assessed for factor VIII (FVIII) level, von Willebrand factor (VWF) antigen (VWF:Ag), VWF activity (VWF:RCo or VWF:GPIbM), thromboelastography (TEG), and thrombin generation assay (TGA) at all points, and for VWF propeptide (VWFpp):Ag ratio and ABO blood type at baseline. Carriers were older than control patients (median age, 34 and 21 years, respectively; P = .003) and had higher ISTH-BAT bleeding scores (median bleeding score, 8 and 0, respectively; P = .001). Carriers had a significantly reduced FVIII response to DDAVP compared with control patients (P ≤ .0001). When only carriers with normal baseline FVIII levels (n = 10) were included, carriers maintained a reduced FVIII response (P ≤ .0001). Furthermore, participants with abnormal bleeding scores had a significantly lower FVIII response to DDAVP compared with those with normal bleeding scores (P = .036). Hemophilia A carriers have a lower and less sustained FVIII response to DDAVP, suggesting an impaired ability to respond to hemostatic stress, which contributes to bleeding.
引用
- Candy V, Whitworth H, Grabell J, et al. A decreased and less sustained desmopressin response in hemophilia A carriers contributes to bleeding. Blood Adv. 2018. PMID: 30327371. doi:10.1182/bloodadvances.2018023713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。